期刊文献+

两种不同RAS抑制剂与胺碘酮联合应用在高血压合并阵发性房颤中的疗效对比 被引量:7

Curative Effect of Two Different RAS Inhibitors Combined with Amiodarone Therapy Hypertensive Patients with Paroxysmal Atrial Fibrillation
下载PDF
导出
摘要 目的探讨坎地沙坦酯、依那普利与胺碘酮联合应用在高血压合并阵发性房颤中的效果。方法整群选取2012年5月—2014年2月该院收治的83例高血压合并阵发性房颤病人,按照随机数字表法分为A组(n=41)和B组(n=42)。A组给予坎地沙坦酯、胺碘酮联合治疗,B组给予依那普利、胺碘酮联合治疗,对比两组治疗效果。结果 A组、B组治疗后6个月、12个月的SBP水平、DBP水平、房颤发作次数均显著地低于治疗前(P<0.05);A组、B组治疗后6个月、治疗后12个月左心房内径与治疗前相比,差异无统计学意义(P>0.05);A组、B组组间治疗前、治疗后6个月、治疗后12个月的SBP水平、DBP水平、左心房内径大小、房颤发作次数相比,差异无统计学意义(P>0.05)。结论坎地沙坦酯或者依那普利联合胺碘酮均可有效地治疗高血压合并阵发性房颤,效果确切。 Objective To investigate effect of candesartan cilexetil, enalapril combined with amiodarone therapy hypertensive patients with paroxysmal atrial fibrillation. Methods 83 patients were randomly divided into two groups. Group A was given candesartan cilexetilamiodarone, while Group B was given enalapril and amiodarone. Results SBP,DBP and atrial fibrillation of 6months and 12 months in two groups was lower than pre-treatment(P<0.05). Comparing pre-treatment,atrial fibrillation of 6 months and 12 months in two groups had no difference(P>0.05). SBP,DBP,atrial fibrillation and left atrium of pre-treatment,6 months and12 months in two groups had no significant difference(P>0.05). Conclusion Candesartan cilexetil, enalapril combined with amiodarone has a good effect.
作者 宋金燕
出处 《中外医疗》 2015年第23期117-118,共2页 China & Foreign Medical Treatment
关键词 高血压 阵发性房颤 坎地沙坦酯 依那普利 胺碘酮 Hypertensive Paroxysmal atrial fibrillation Candesartan cilexetil Enalapril Amiodarone
  • 相关文献

参考文献6

二级参考文献29

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1399
  • 2郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 3黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
  • 4Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recurrence of atrial fibrillation.Canadian Trial of Atrial Fibrillation Ivestigatos[J].N Engl J Med,2000,342(13):913-920. 被引量:1
  • 5Yin Y,Dalal D,Liu Z,et al.Prospective randomized study Comparing amiodarone vs.amiodarone plus losartan vs.amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation[J].European Heart Journal,2006,27(15):1841-1846. 被引量:1
  • 6Madrid AH,Escobar C,Rellb JM,et al.Angiotensin receptor blockar as adjunctive therapy for rhytm control in atrial fibrillation:results of the irbesartan-amio drone trial[J].Gard Electrophysiol Rev,2003,7(3):243-246. 被引量:1
  • 7Burstein B,Nattel S.Atrial fibrosis:mechanisms and clinical relevance in atrial fibrillation[J].J Am Coll Cardiol,2008,51(8):802-809. 被引量:1
  • 8Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary[J].Circulation,2006,l14:700-752. 被引量:1
  • 9Asanin M,Vasiljevie Z,Matic M. Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarction[J].{H}CARDIOLOGY,2007,(3):197-202. 被引量:1
  • 10郭继鸿;胡大一.中国心律学(2010年版)[M]{H}北京:人民卫生出版社,2010121. 被引量:1

共引文献43

同被引文献31

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部